EUVIMEDEUVIMED entdecken
Crossref

The assembly of cancer-specific ribosomes by the lncRNA LISRR suppresses melanoma anti-tumor immunity

Sonia Cinque iD, Yvessa Verheyden iD, Sara Adnane iD, Alessandro Marino iD, Sarah Hanache iD, Roberto Vendramin iD, Alessandro Cuomo iD, Joanna Pozniak iD, Alvaro Cortes Calabuig iD, Marcella Baldewijns iD, Sébastien Tabruyn iD, Oliver Bechter iD und 4 weitere

Journal of Experimental Medicine · 2026

DOI: 10.1084/jem.20251507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Sonia Cinque und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Laboratory for RNA Cancer Biology, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Ribosomes, Melanoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: KU Leuven, Belgian Federation for Cancer, Melanoma Research Alliance Amanda and Jonathan Eilian young.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gains of chromosome 12p11.21, encoding for the cancer-specific lncRNA LISRR, correlate with poor survival across different cancers. In melanoma, LISRR is upregulated in immunotherapy-resistant patients to contribute to the generation of drug-tolerant cells by activating an immune-suppressive translational program, affecting the synthesis of PD-L1 and of the glycocalyx. Accordingly, downregulation of LISRR initiates robust immune responses and resensitizes to immunotherapy ex vivo and in vivo. The use of glycans to evade immunity exhibits shared characteristics with the testis, where defects in the glycocalyx cause infertility. Mechanistically, we showed that LISRR affects the ribosome core composition and recruits deleted in azoospermia-associated protein 1 to polysomes to prime the integrated stress response. Our study reveals the contribution of lncRNAs to the generation of cancer-specific ribosomes and identifies an RNA-based strategy to overcome resistance to immune checkpoint blockade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingRibosomesMelanomaHumansAnimalsMiceCell Line, TumorMaleGene Expression Regulation, NeoplasticB7-H1 AntigenImmunotherapy

Substanzen

RNA, Long NoncodingB7-H1 Antigen

Autor:innen und Institutionen

  • Department of Oncology, Laboratory for RNA Cancer Biology, KU Leuven, Leuven, Belgium.
  • Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium.
  • Department of Human Genetics, Laboratory for Cytogenetics and Genome Research, KU Leuven, Leuven, Belgium.
  • Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
  • TransCure bioServices , Archamps, France.

ORCID-Profile: Sonia Cinque, Yvessa Verheyden, Sara Adnane, Alessandro Marino, Sarah Hanache, Roberto Vendramin, Alessandro Cuomo, Joanna Pozniak, Alvaro Cortes Calabuig, Marcella Baldewijns, Sébastien Tabruyn, Oliver Bechter, Maria Francesca Baietti, Elisabetta Groaz, Tiziana Bonaldi, Eleonora Leucci

Förderung

  • KU Leuven
  • Belgian Federation for Cancer
  • Melanoma Research Alliance Amanda and Jonathan Eilian young
  • Italian Association for Cancer Research
  • European Proteomics Infrastructure Consortium providing access
  • Horizon 2020 programme of the European Union
  • Flanders Research Organization

Zitieren

APA

Cinque, S., Verheyden, Y., Adnane, S., Marino, A., Hanache, S., Vendramin, R., Cuomo, A., Pozniak, J., Cortes Calabuig, A., Baldewijns, M., Tabruyn, S., Bechter, O., Baietti, M. F., Groaz, E., Bonaldi, T., & Leucci, E. (2026). The assembly of cancer-specific ribosomes by the lncRNA LISRR suppresses melanoma anti-tumor immunity. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20251507

Vancouver

Cinque S, Verheyden Y, Adnane S, Marino A, Hanache S, Vendramin R, et al. The assembly of cancer-specific ribosomes by the lncRNA LISRR suppresses melanoma anti-tumor immunity. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20251507

BibTeX
@article{Cinque2026,
  author = {Cinque, Sonia and Verheyden, Yvessa and Adnane, Sara and Marino, Alessandro and Hanache, Sarah and Vendramin, Roberto and Cuomo, Alessandro and Pozniak, Joanna and Cortes Calabuig, Alvaro and Baldewijns, Marcella and Tabruyn, Sébastien and Bechter, Oliver and Baietti, Maria Francesca and Groaz, Elisabetta and Bonaldi, Tiziana and Leucci, Eleonora},
  title = {The assembly of cancer-specific ribosomes by the lncRNA LISRR suppresses melanoma anti-tumor immunity},
  journal = {Journal of Experimental Medicine},
  year = {2026},
  doi = {10.1084/jem.20251507}
}
Kostenlos starten →